We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,146

European markets less than enthusiastic over biosimilars
  • Shook Hardy & Bacon LLP
  • European Union, USA
  • December 12 2013

While Europe has had a regulatory approval pathway for biosimilar drug products for some years, their use reportedly remains anemic. Physicians are

Africa update - November 6, 2014
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • Africa, European Union, Global, USA
  • November 6 2014

On October 29th, the U.S. Agency for International Development (USAID) issued a new fact sheet on the Ebola outbreak. The fact sheet highlighted the

The antidote - September 2014
  • CMS Cameron McKenna
  • European Union, United Kingdom, USA
  • September 9 2014

Summer is nearly at an end and whilst corporate activity continued apace, including AbbVie acquiring Shire, Omega Pharma attracting acquisition

Global corporate insurance & regulatory bulletin
  • Mayer Brown JSM
  • China, European Union, United Kingdom, USA
  • December 5 2013

The China Insurance Regulatory Commission (“CIRC”) announced new rules (Implementing Rules of Provisional Measures on Outbound Investments with

US and European approaches to antibody patents
  • FB Rice
  • European Union, USA
  • June 13 2013

When monoclonal antibodies were first produced in 1974, Kohler and Milstein predicted that they “could be valuable for medical and industrial use”

Kartellrechtliche fallstricke im life science-bereich
  • Baker & McKenzie
  • European Union, France, USA
  • May 24 2013

Im Wettbewerb gegen Generika ist Vorsicht geboten: Verschiedene Maßnahmen gegen den Markteintritt kostengünstigerer Generika werden

Patent claims for ‘personalised medicines’
  • Mewburn Ellis LLP
  • European Union, USA
  • February 7 2013

As previously reported the US Supreme Court, in Mayo v. Prometheus, recently invalidated Prometheus's diagnostic claims - directed to a method of

Measure - Summer 2013
  • King & Spalding LLP
  • European Union, Middle East, Saudi Arabia, United Arab Emirates, USA
  • July 3 2013

This issue is rich in news on emerging market trends and legal developments. A revival in real estate investments has been witnessed across the globe

Unlocking the Promise of Personalized Medicine: Reimbursement, Coverage, and Clinical Utility
  • Foley & Lardner LLP
  • European Union, USA
  • September 15 2014

AmerisourceBergen, in connection with the Business of Personalized Medicine Summit, released "Unlocking the Promise of Personalized Medicine:

Global intellectual property newsletter - issue 0115
  • Clifford Chance LLP
  • China, European Union, Germany, Poland, Spain, United Kingdom, USA
  • January 21 2015

Establishment of the Unified European Patent Litigation System has been subject to many efforts of European leaders and legislators for more than four